GIM
MDCO

Granahan Investment Management’s Medicines Co MDCO Stock Holding History

Granahan Investment Management’s Portfolio MDCO Stock Details MDCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-275,712
Closed -$23.4M – 201
2019
Q4 		$23.4M Sell
275,712
-166,449
-38% -$11.1M 1.08% 24
2019
Q3 		$22.1M Buy
442,161
+3,039
+0.7% +$121K 1.22% 20
2019
Q2 		$16M Sell
439,122
-59,421
-12% -$1.94M 0.79% 38
2019
Q1 		$13.9M Sell
498,543
-23,977
-5% -$565K 0.75% 43
2018
Q4 		$10M Sell
522,520
-7,785
-1% -$181K 0.71% 48
2018
Q3 		$15.9M Sell
530,305
-23,543
-4% -$887K 0.86% 36
2018
Q2 		$20.3M Buy
553,848
+73,662
+15% +$2.39M 1.22% 20
2018
Q1 		$15.8M Buy
480,186
+420,470
+704% +$13.1M 1.14% 21
2017
Q4 		$1.63M Buy
59,716
+26,768
+81% +$824K 0.13% 154
2017
Q3 		$1.22M Buy
+32,948
New +$1.21M 0.1% 152

Other funds holding MDCO

GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Granahan Investment Management's MDCO Position: Q1 2020 in Review

Granahan Investment Management sold out of Medicines Co (MDCO) in Q1 2020, closing a stake of 275,712 shares — an estimated $23.4M sold.

Granahan Investment Management first reported a position in MDCO in Q3 2017 and held it in 10 quarters. The position peaked at $23.4M in Q4 2019. 1 fund tracked by Wall St. Rank holds MDCO as of Q1 2020.

  • Granahan Investment Management reported no remaining Medicines Co position as of Q1 2020 after selling out during the quarter.
  • Granahan Investment Management sold 275,712 Medicines Co shares in Q1 2020, an estimated $23.4M.
  • Granahan Investment Management first reported a position in Medicines Co in Q3 2017 and held it in 10 quarters.
  • Granahan Investment Management's Medicines Co position peaked at $23.4M in Q4 2019.
  • 1 fund tracked by Wall St. Rank held Medicines Co as of Q1 2020.

Based on Granahan Investment Management's 13F filing for Q1 2020, filed 12 May 2020.